Lilly(Eli) & Co (NYSE: LLY) on Friday, soared 3.29% from the previous trading day, before settling in for the closing price of $733.29. Within the past 52 weeks, LLY’s price has moved between $677.09 and $972.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 15.54%. The company achieved an average annual earnings per share of 67.93%. With a float of $849.67 million, this company’s outstanding shares have now reached $948.10 million.
Let’s determine the extent of company efficiency that accounts for 47000 employees. In terms of profitability, gross margin is 81.7%, operating margin of 41.41%, and the pretax margin is 27.75%.
Lilly(Eli) & Co (LLY) Insider Activity
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Lilly(Eli) & Co is 10.34%, while institutional ownership is 79.01%. The most recent insider transaction that took place on May 14 ’25, was worth 936,550. In this transaction EVP & President, LLY Int’l of this company sold 1,250 shares at a rate of $749.24, taking the stock ownership to the 27,510 shares. Before that another transaction happened on May 14 ’25, when Company’s Officer proposed sale 2,500 for $749.24, making the entire transaction worth $1,873,100.
Lilly(Eli) & Co (LLY) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 67.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.44% during the next five years compared to 18.77% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Lilly(Eli) & Co (LLY) is currently performing well based on its current performance indicators. A quick ratio of 1.06 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.65. Likewise, its price to free cash flow for the trailing twelve months is 192.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 12.07, a number that is poised to hit 5.54 in the next quarter and is forecasted to reach 29.69 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Looking closely at Lilly(Eli) & Co (NYSE: LLY), its last 5-days average volume was 6.22 million, which is a jump from its year-to-date volume of 4.05 million. As of the previous 9 days, the stock’s Stochastic %D was 20.60%. Additionally, its Average True Range was 34.34.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 31.06%, which indicates a significant increase from 23.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.51% in the past 14 days, which was higher than the 46.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $801.97, while its 200-day Moving Average is $838.89. However, in the short run, Lilly(Eli) & Co’s stock first resistance to watch stands at $764.84. Second resistance stands at $772.29. The third major resistance level sits at $785.71. If the price goes on to break the first support level at $743.97, it is likely to go to the next support level at $730.55. Should the price break the second support level, the third support level stands at $723.10.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
Market capitalization of the company is 717.81 billion based on 947,736K outstanding shares. Right now, sales total 45,043 M and income totals 10,590 M. The company made 12,729 M in profit during its latest quarter, and 2,759 M in sales during its previous quarter.
